North Star Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

North Star Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-366	Closed	-$31K	–	975
2020 Q1	$31K	Hold	366	–	–	﹤0.01%	567
2019 Q4	$31K	Sell	366 -1	-0.3%	-$76	﹤0.01%	643
2019 Q3	$25K	Buy	+367	New	+$28.3K	﹤0.01%	676
2019 Q2	–	Sell	-367	Closed	-$33K	–	445
2019 Q1	$33K	Hold	367	–	–	﹤0.01%	629
2018 Q4	$31K	Buy	367 +1	+0.3%	+$95	﹤0.01%	602
2018 Q3	$35K	Hold	366	–	–	﹤0.01%	625
2018 Q2	$34K	Hold	366	–	–	﹤0.01%	634
2018 Q1	$30K	Buy	+366	New	+$31.4K	﹤0.01%	655

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

North Star Investment Management's BMRN Position: Q2 2020 in Review

North Star Investment Management sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2020, closing a stake of 366 shares — an estimated $31K sold.

North Star Investment Management first reported a position in BMRN in Q1 2018 and held it in 8 quarters. The position peaked at $35K in Q3 2018. 528 funds tracked by Wall St. Rank hold BMRN as of Q2 2020.

North Star Investment Management reported no remaining BioMarin Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
North Star Investment Management sold 366 BioMarin Pharmaceuticals shares in Q2 2020, an estimated $31K.
North Star Investment Management first reported a position in BioMarin Pharmaceuticals in Q1 2018 and held it in 8 quarters.
North Star Investment Management's BioMarin Pharmaceuticals position peaked at $35K in Q3 2018.
528 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2020.

Based on North Star Investment Management's 13F filing for Q2 2020, filed 16 Jul 2020.